InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,340.80
(
0.40%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
86.03
(
0.71%
)
Bitcoin
61,401.05
(
-0.34%
)

Replies to post #239194 on Biotech Values

Replies to #239194 on Biotech Values

DewDiligence

08/13/21 3:51 PM

#239198 RE: DewDiligence #239194

SESN reopens -57% (eom).

DewDiligence

05/03/22 12:20 PM

#242314 RE: DewDiligence #239194

SESN pursuing “strategic alternatives”:

https://www.businesswire.com/news/home/20220503005367/en

The CRL in 2021 contained both CMC and clinical deficiencies (#msg-165435186); today’s PR acknowledges that the clinical deficiencies require a new phase-3 trial.